Patent details
EP2044961 Title: Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
Basic Information
- Publication number:
- EP2044961
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP080208051
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Phospholipid analogues for the treatment of pancreatic, ovarian and colon cancers, melanomas, gliomas, and carcinosarcomas
- French Title of Invention:
- Analogues phospholipidiques pour le traitement des cancers du pancréas, des ovaires et du colon, des mélanomes, gliomes et carcinosarcomes
- German Title of Invention:
- Phospholipid-Analoga für die Behandlung von Pankreas-, Ovarial- and Kolon-Krebs, Melanomen, Gliomen und Karzinosarkomen
- SPC Number:
Dates
- Filing date:
- 02/03/2005
- Grant date:
- 17/07/2013
- EP Publication Date:
- 17/07/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/04/2009
- EP B1 Publication Date:
- 17/07/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/03/2014
- Expiration date:
- 02/03/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/03/2005
- Name:
- Cellectar Inc.
- Address:
- 3301 Agriculture Drive, Madison, WI 53716, United States (US)
Inventor
1
- Name:
- Weichert Jamey
- Address:
- United States (US)
2
- Name:
- Pinchuk Anatoly
- Address:
- United States (US)
3
- Name:
- Longino Marc
- Address:
- United States (US)
Priority
- Priority Number:
- 521166 P
- Priority Date:
- 02/03/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 51/04;
| Filing date | Document type | Number of pages |
|---|